Medications

Drug companies forge partnerships with top schools

(AP)—Pharmaceutical companies that can no longer rely on lucrative patents to drive profits are increasingly teaming up with academia in search of the next big drug discovery.

Alzheimer's disease & dementia

Researchers find new target for Alzheimer's drug development

Researchers at the University of Minnesota's Center for Drug Design have developed a synthetic compound that, in a mouse model, successfully prevents the neurodegeneration associated with Alzheimer's disease.

Diseases, Conditions, Syndromes

US meningitis death toll rises to 30, officials say

The death toll from a meningitis outbreak linked to tainted drugs rose to 30 as the number of cases climbed to a whopping 419, US health officials said Monday.

Diseases, Conditions, Syndromes

US firm loses license as tainted drug toll rises to 24

US officials revoked the license Wednesday of a Massachusetts pharmacy cited for significant sanitary violations as the toll from a meningitis outbreak tied to its tainted drugs rose to 24.

Diseases, Conditions, Syndromes

US meningitis death toll up to 23: CDC

The death toll in the United States from an unprecedented outbreak of fungal meningitis linked to a contaminated drug has climbed to 23 people, health officials said Saturday.

Diseases, Conditions, Syndromes

US meningitis outbreak death toll rises to 15

The death toll from an unprecedented US meningitis outbreak tied to a tainted steroid jumped to 15 after another person died from a fungal form of the disease, health authorities said Saturday.

Diseases, Conditions, Syndromes

US tainted drug outbreak rises to 185 cases

The number of people believed to have been sickened by a contaminated drug rose to 185 Friday, but US health officials said the death toll from the rare meningitis outbreak held steady at 14.

Medications

Calls for more US oversight after tainted drug outbreak

A deadly meningitis outbreak in the United States blamed on a tainted drug has triggered outrage and calls for tighter regulation of the loosely controlled pharmaceutical compounding industry.

page 12 from 16